Skip to main content

Relevant metabolism of cardiac glycosides

  • Conference paper
Cardiac Glycosides 1785–1985
  • 99 Accesses

Summary

With regard to the metabolism of digitalis glycosides, recent experiments show that cleavage of the sugar residues in the liver is not simple hydrolysis but an oxidative process which is catalyzed by the cytochrome P 450 system.

The enzymatic 12 β-hydroxylation of digitoxin to digoxin is quantitatively neglisible in man.

The pattern of digitoxin and digoxin metabolites, which is found to be fairly inhomogeneous in various studies, considerably depends on the different experimental designs, for instance, on the mode of administration. The relatively low recovery of the glycosides and their metabolites in urine and (if investigated) also in feces makes the evaluation of metabolism and its magnitude more difficult. Approximately, digitoxin is metabolized to 20–50%, digoxin to 5–50%.

With respect to strophanthus glycosides, an insufficient recovery was also noted in most of the studies. In contrast to ouabain, cymarin and orally given k-strophanthoside were found to be highly metabolized in urine. Intravenously injected k-strophanthoside was excreted in urine mainly as unchanged drug.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Doherty JE (1968) The clinical pharmacology of digitalis glycosides: A review. Am J Med Sci 255: 382 – 412

    Article  PubMed  CAS  Google Scholar 

  2. Doherty JE (1973) Digoxin: present knowledge of pharmacokinetics and pharmacodynamics. In: Storstein O (ed) Symposium on Digitalis. Gyldendal Norsk Forlag, Oslo, p 419

    Google Scholar 

  3. Gault MH, Longerich LL, Loo JCK, Ko PTH, Fine A, Vasder SC, Dawe MA (1984) Digoxin biotransformation. Clin Pharmacol Ther 35: 74 – 82

    Article  PubMed  CAS  Google Scholar 

  4. Herrmann I, Repke K (1963) Über die Biotransformation von Digitoxin und Digitoxigenin in der menschlichen Leber. Monatsber Dtsch Akad Wissenschaften Berlin 5: 140 – 143

    CAS  Google Scholar 

  5. Kuhlmann J, Abshagen U, Rietbrock N (1974) Pharmacokinetics and metabolism of digoxigeninmonodigitoxoside in man. Eur J Clin Pharmacol 7: 87 – 94

    Article  PubMed  CAS  Google Scholar 

  6. Kuhlmann J (1981) Metabolismus von Digitoxin. In: Digitâlistherapie bei Herzinsuffizienz, S. 9. Intern Symposium in Taormina, 8.-12.6.1980. -Urban + Schwarzenberg Verlag, Berlin Wien Baltimore

    Google Scholar 

  7. Lukas DS (1973) Pharmacokinetics andmetnbolism’df digitoxin in man. In: Symposium on digitalis. Storstein O (ed). Oslo: Gyldendal Norsk Forlag, pp 84 – 102

    Google Scholar 

  8. Lukas DS (1978) Studies of the metabolism of digoxin and digitoxin using double isotope dilution derivative methods. In: Bodem G, Dengler HJ (eds) Cardiac glycosides, Part I, International Boehringer Mannheim Symposia. Springer-Verlag, Berlin Heidelberg New York, p 36

    Google Scholar 

  9. Magnussen JO, Bergdahl B, Bogenstoft C, Jonsson UE, Tekenbergs L (1982) Excretion of digoxin and its metabolites in urine after a single oral dose in healthy subjects. Biopharm & Drug Disp 3: 21–118

    Google Scholar 

  10. Magnussen JO (1983) Metabolism of digoxin after oral and intrajejunal administration. Br J Clin Pharmac 16: 741 – 742

    Article  Google Scholar 

  11. Marcus FI, Burkhalter L, Cuccia C, Pavlovich J, Kapadia GG (1966) Administration of tritiated digoxin with and without a loading dose. A metabolic study. Circulation 24: 865–874

    Google Scholar 

  12. Okita GT, Talso PJ, Curry JH, Smith FD, Geiling EMK (1955) Metabolic fate of radioactive digitoxin in human subjects. J Pharmacol 115: 371 – 379

    CAS  Google Scholar 

  13. Okita GT (1964) Metabolism of radioactive cardiac glycosides. Pharmacologist 6: 45

    Google Scholar 

  14. Repke K (1959) Über Spaltung und Hydroxylierung von Digitoxin bei der Ratte. Naunyn Schmiedeberg’s Arch Exp Path Pharmakol 237: 34 – 48

    CAS  Google Scholar 

  15. Repke K (1966) Biochemie und Klinik der Digitalis. Internist 7: 418 – 426

    PubMed  CAS  Google Scholar 

  16. Repke K (1970) Stoffwechsel und Wirkung von Digitalisglykosiden. Ost Apoth Ztg 24: 515

    CAS  Google Scholar 

  17. Rietbrock N, Vöhringer HF, Kuhlmann J (1977) Der Metabolismus herzwirksamer Glykoside. Herz/ Kreisl 9: 825 – 832

    CAS  Google Scholar 

  18. Rietbrock N, Woodcock BG (1981) Pharmacokinetics of digoxin and derivatives. In: Greeff K (Hrsg) Cardiac Glycosides. Handbuch der experimentellen Pharmakologie, Vol 56 /11. Springer-Verlag, Berlin Heidelberg New York

    Google Scholar 

  19. Rojsathaporn K (1982) Zur Pharmakokinetik der Strophanthusglykoside beim Menschen. Inaugural-Dissertation, Düsseldorf

    Google Scholar 

  20. Schmoldt A, Benthe HF, Haberland G (1975) Digitoxin metabolism by rat liver microsomes. Biochem Pharmacol 24: 1639 – 1641

    Article  PubMed  CAS  Google Scholar 

  21. Schmoldt A (1984) Untersuchungen zum Metabolismus der Digitalisglykoside. Beiträge zur gerichtl Medizin 42: 95 – 101

    CAS  Google Scholar 

  22. Selden R, Margolies N, Smith TW (1974) Renal and gastrointestinal excretion of ouabain in dog and man. J Pharmacol Exp Ther 188: 615 – 623

    PubMed  CAS  Google Scholar 

  23. Storstein L (1977) Studies on digitalis. VIII. Digitoxin metabolism on a maintenance regimen and after a single dose. Clin Pharmacol Ther 21: 125 – 140

    PubMed  CAS  Google Scholar 

  24. Storstein L (1981) Pharmacokinetics of digitoxin. In: Cardiac Glycosides. Handbook of Experimental Pharmacology, Vol 56/II, S 3, Greeff K (ed), Springer-Verlag, Berlin Heidelberg New York

    Google Scholar 

  25. Vöhringer HF, Rietbrock N (1974) Metabolism and excretion of digitoxin in man. Clin Pharmacol Ther 16: 796 – 806

    PubMed  Google Scholar 

  26. Vöhringer HF, Rietbrock N (1978) Pharmacokinetics and Metabolism of Digitoxin in the human. In: Bodem, G, Dengler, HJ (eds) Cardiac Glycosides, Part I. International Boehringer Mannheim Symposia. Springer-Verlag, Berlin Heidelberg New York, p 64

    Chapter  Google Scholar 

  27. Wirth KE, Frölich JC, Hollefield JW, Falkner FC, Sweetman BS, Oates JA (1976) Metabolism of digitoxin in man and its modification by spironolactone. Eur J Clin Pharmacol 9: 345 – 354

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Wirth, K.E. (1986). Relevant metabolism of cardiac glycosides. In: Erdmann, E., Greef, K., Skou, J.C. (eds) Cardiac Glycosides 1785–1985. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-662-11292-2_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-11292-2_33

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-662-11294-6

  • Online ISBN: 978-3-662-11292-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics